3:51 PM
 | 
Feb 28, 2017
 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Cytomegalovirus (CMV)

Studies in cells suggest a bacterial toxin-based inhibitor of US28 could help treat latent CMV infection. In a human monocyte cell line expressing US28, a fusion protein consisting...

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >